🇺🇸 FDA
Patent

US 9517241

Amelioration of intestinal fibrosis and treatment of Crohn's disease

granted A61KA61K31/59A61K31/592

Quick answer

US patent 9517241 (Amelioration of intestinal fibrosis and treatment of Crohn's disease) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/59, A61K31/592, A61K45/06, A61K9/0053